Scrip's Five Must-Know Things - 21 October 2024

Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 October 2024. In this episode: J&J looks to Tremfya as Stelara declines; Pfizer’s Hympavzi may find hemophilia B niche; big pharma’s cell and gene therapy realities; M&A took a holiday in Q3; and last rites for Sanofi’s RIPK1 drug. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-CMKHTUFVBBDQ3DSTX3KJALGCQI/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Episode metadata supplied by the publisher feed · Published Oct 21, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Scrip's Five Must-Know Things - 21 October 2024

0:00 15:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 15 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on October 21, 2024.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!